ALPHATEC HOLDINGS, INC. Effective Income Tax Rate Reconciliation, Tax Settlement, Foreign, Percent
ALPHATEC HOLDINGS, INC. (ATEC) reported Effective Income Tax Rate Reconciliation, Tax Settlement, Foreign, Percent of -0.02% for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign · last filed 2026-02-24
- ALPHATEC HOLDINGS, INC. effective income tax rate reconciliation, tax settlement, foreign, percent for fiscal 2024 was -0.02%.
- ALPHATEC HOLDINGS, INC. effective income tax rate reconciliation, tax settlement, foreign, percent for fiscal 2023 was -0.07%.
- ALPHATEC HOLDINGS, INC. effective income tax rate reconciliation, tax settlement, foreign, percent for fiscal 2022 was -0.05%.
- ALPHATEC HOLDINGS, INC. effective income tax rate reconciliation, tax settlement, foreign, percent for fiscal 2021 was -0.05%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Settlement, Foreign, Percent 12 month |
|---|---|
| 2024-12-31 | -0.02% 10-K · filed 2026-02-24 |
| 2023-12-31 | -0.07% 10-K · filed 2026-02-24 |
| 2022-12-31 | -0.05% 10-K · filed 2025-02-26 |
| 2021-12-31 | -0.05% 10-K · filed 2024-02-27 |
| 2020-12-31 | -0.04% 10-K · filed 2023-02-28 |
| 2019-12-31 | 19.19% 10-K · filed 2020-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |